Minerva Neurosciences, Inc. Increase (Decrease) in Other Accrued Liabilities
Minerva Neurosciences, Inc. (NERV) reported Increase (Decrease) in Other Accrued Liabilities of -$1.22 million for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccruedLiabilities · last filed 2016-08-04
- Minerva Neurosciences, Inc. increase (decrease) in other accrued liabilities for the quarter ending 2015-12-31 was $0.00.
- Minerva Neurosciences, Inc. increase (decrease) in other accrued liabilities for the quarter ending 2015-09-30 was -$1.08M.
- Minerva Neurosciences, Inc. increase (decrease) in other accrued liabilities for the quarter ending 2015-06-30 was -$383.13K.
- Minerva Neurosciences, Inc. increase (decrease) in other accrued liabilities for the quarter ending 2015-03-31 was $238.92K.
- Minerva Neurosciences, Inc. increase (decrease) in other accrued liabilities for fiscal 2015 was -$1.22M, a 200.00% decline from fiscal 2014.
- Minerva Neurosciences, Inc. increase (decrease) in other accrued liabilities for fiscal 2014 was $1.22M.
| Period end | Increase (Decrease) in Other Accrued Liabilities 3 month | Increase (Decrease) in Other Accrued Liabilities 6 month | Increase (Decrease) in Other Accrued Liabilities 9 month | Increase (Decrease) in Other Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | -$1.08M derived: sum of 2 quarters · filed 2016-03-14 | -$1.46M derived: sum of 3 quarters · filed 2016-08-04 | -$1.22M 10-K · filed 2016-03-14 |
| 2015-09-30 | -$1.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | -$1.46M derived: sum of 2 quarters · filed 2016-08-04 | -$1.22M 10-Q · filed 2015-11-05 | -$1.39M derived: sum of 4 quarters · filed 2016-08-04 |
| 2015-06-30 | -$383.13K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | -$144.21K 10-Q · filed 2016-08-04 | -$308.28K derived: sum of 3 quarters · filed 2016-08-04 | |
| 2015-03-31 | $238.92K 10-Q · filed 2016-05-03 | $74.85K derived: sum of 2 quarters · filed 2016-05-03 | ||
| 2014-12-31 | -$164.07K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $1.22M 10-K · filed 2016-03-14 | ||
| 2014-09-30 | $1.39M 10-Q · filed 2015-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |